On Tuesday, October 6 at 1 p.m. BST, NSF International will present a complimentary webinar on nitrosamine impurities and the impact on IMPs.
Hosted by expert Paul Cummings, the webinar will introduce the topic of what needs to be considered during development of an IMP, the risks of delaying a formal risk assessment and the potential commercial impact, with the ultimate aim of a safe and efficacious product being granted a marketing authorisation.